1.Traumatic dislocation of peroneal tendons: one case report.
Seung Ho YUNE ; Kwang Jin RHEE ; Deug Soo HWANG ; Sang Deug LIM ; Gyu Jong CHOI
The Journal of the Korean Orthopaedic Association 1992;27(7):1949-1954
No abstract available.
Dislocations*
;
Tendons*
2.Diffuse alveolar hemorrhage as a rare complication in a patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)
Jeong-Cheol Lim ; Eun Joo Chung ; Sang Jin Kim ; Eung Gyu Kim
Neurology Asia 2013;18(1):113-116
Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a syndrome
with complex genetics and diverse manifestations. Diffuse alveolar hemorrhage is caused by alveolar
microcirculation injury associated with lung illness or systemic disorders. To date, the relationship
between diffuse alveolar hemorrhage and MELAS has not been reported. We report a MELAS patient
who presented complications with diffuse alveolar hemorrhage.
3.Intracranial hemorrhage in full-term neonates by ultrasonography.
Chang Gyu LIM ; Joon Soo PARK ; Woo Ryong LEE ; Jae Ock PARK ; Sang Mann SHIN ; Sang Jhoo LEE
Journal of the Korean Pediatric Society 1993;36(11):1570-1577
Intracranial hemorrhage is the most common neuropathologic finding in premature infants. But in full-term infants, it is less common and rarely causes death. We found out intracranial hemorrhages in 21 full-term neonates by real-time neurosonography and concluded as followings. 1) Among 21 neonates, 17 infants were male and 4 infants were female. 2) In 11 (52.3%) infants the hemorrhage was detected within 7 days after birth. 3) The intracranial hemorrhage was not related with delivery type nor Apgar score. 4) In 13 cases (61.9%) the hemorrhage was in the subependymal germinal matrix and the degree was Grade I. 5) Precipitating or associated factors were asphyxia, pneumonia, ventilator care, RDS and congenital heart disease. 6) Symptoms and signs were seizure, apnea, lethargy, cyanosis, jaundice, anemia or bulging fontanel.
Anemia
;
Apgar Score
;
Apnea
;
Asphyxia
;
Cyanosis
;
Female
;
Heart Defects, Congenital
;
Hemorrhage
;
Humans
;
Infant
;
Infant, Newborn*
;
Infant, Premature
;
Intracranial Hemorrhages*
;
Jaundice
;
Lethargy
;
Male
;
Parturition
;
Pneumonia
;
Seizures
;
Ultrasonography*
;
Ventilators, Mechanical
4.A Case of Peripartum Cardiomyopathy.
Sang Bum HA ; Yong Suk CHOI ; Jong Oh KIM ; Seong Lim LEE ; Seung Gyu SONG ; Bong Choon JO
Korean Journal of Perinatology 2001;12(3):384-387
No abstract available.
Cardiomyopathies*
;
Peripartum Period*
5.Chylous Ascites in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis.
Young Jun KIM ; Gyu Chul LIM ; Sun Ae LEE ; Chong Ik JUNG ; Jin Hwui KIM ; Duk Ho KWON ; Sang Yong JUNG ; Sang Yeol SUH
Korean Journal of Nephrology 1998;17(4):649-652
Chylous ascites is extravasation of lymphatic fluid and retention in the peritoneal cavity due to traurna or obstruction of the lymphatic system. Chylous ascites is very rare complication of Continuous Ambulatory Peritoneal Dialysis (CAPD) and is associated with trauma to the lymphatics during catheter insertion in the early stage of CAPD and repeated mild trauma to the lyrnphatics during longterm dialysis. Chylous ascites in the CAPD is suspected when the drained peritoneal fluid is milky white and confirmed by demonstration of the specific components of chyle, such as elevated triglyceride and low cholesterol than plasma and should be differentiated from pseudochyle and bacterial peritonitis. We report a case of chylous ascites in a patient undergoing CAPD at 2 months later of initiation of CAPD, which was not improved by conservative management. So CAPD catheter was removed and renal replacement therapy was changed to hemodialysis.
Ascitic Fluid
;
Catheters
;
Cholesterol
;
Chyle
;
Chylous Ascites*
;
Dialysis
;
Humans
;
Lymphatic System
;
Peritoneal Cavity
;
Peritoneal Dialysis, Continuous Ambulatory*
;
Peritonitis
;
Plasma
;
Renal Dialysis
;
Renal Replacement Therapy
;
Triglycerides
6.Pavlov’s Ratio of the Cervical Spine in a Korean Population: A Comparative Study by Age in Patients with Minor Trauma without Neurologic Symptoms
Myung-Sang MOON ; Won Rak CHOI ; Hyeon Gyu LIM ; Sang-Yup LEE ; Seung Myung WI
Clinics in Orthopedic Surgery 2021;13(1):71-75
Background:
There are many studies on the vertebral body-to-canal ratio, the so-called Pavlov’s ratio of the cervical spine. However, there are no studies on its relation with age to clarify each bony component’s contribution to the spinal canal formation and its size. The aim of this study was to investigate differences and changes in the vertebral body-to-canal ratio according to age in an asymptomatic population.
Methods:
This is a cross-sectional study of 280 asymptomatic individuals. A total of 140 men and 140 women representing each decade of life from the first to the seventh were included in this study. The anteroposterior length of the vertebral body and canal from C3 to C6 was measured on sagittal radiographs to calculate the vertebral body-to-canal ratio.
Results:
The average Pavlov’s ratio was significantly larger (p < 0.001) in the first decade of life. The average Pavlov’s ratio of the individuals in the first decade of life was 1.09 between C3 and C6 (1.08 at C3, 1.07 at C4, 1.11 at C5, and 1.13 at C6; range, 0.78–1.51). There was no significant difference among the other decades of life.
Conclusions
We assessed the Pavlov’s ratio of the cervical spine in an asymptomatic population. It is our belief that the spinal canal size is the largest in the first decade of life, and the Pavlov’s ratio becomes almost fixed throughout life after maturity.
7.Autonomic Dysfunction in Chronic Renal Failure.
Sang Ho LEE ; Soo Chul CHOI ; Seoung Pyo HONG ; Tae Won LEE ; Chun Gyu LIM ; Myung Jae KIM
Korean Journal of Medicine 1998;55(2):221-231
OBJECTIVES : Impaired autonomic function in patients with chronic renal failure has been well documented in a number of studies to assess the degree of cardiovascular autonomic dysfunction and to assess the relationship with plasma catecholamines. The purpose of the present study was to evaluate the prevalence of autonomic dysfunction and to determine the effect of autonomic dysfunction on the increment of plasma catecholamine, dialysis-induced hypotension and hypotension during chronic dialysis. METHODS: We measured the degree of autonomic damage and the concentration of plasma catecholamines in 20 patients on maintenance hemodialysis, 12 pre- dialysis patients with chronic renal failure and 20 normal controls using a standardized battery of five cardiovascular reflex tests. RESULTS: 1) In normal controls, 70% of cases had a normal or early parasympathetic abnormalities however in patients with chronic renal failure, 45.2% of patients had severe abnormalities. The prevalence of autonomic dysfunction was 62.5% and there was significant correlation between sympathetic and parasympathetic score in patients with chronic renal failure. 2) Although overall autonomic function was not different in two chronic renal failure groups, the magnitude of heart rate response to Valsalva maneuver was increased and the magnitude of fall of blood pressure in response to standing-up was reduced in dialyzed patients compared with nondialyzed patients. 3) Patients with autonomic dysfunction was older and had higher postdialysis concentration of plasma norepinephrine than those with normal autonomic function. 4) In dialyzed patients, predialysis concentration of plasma norepinephrine at rest varied widely and was significantly related to the duration of dialysis. Postdialysis concentration of norepinephrine was significantly correlated with the degree of parasympathetic damage. 5) There were no significant differences in autonomic damage or plasma catecholamines whether dialysis- induced hypotension and hypotension in chronic hemodialysis or not. CONCLUSION : Disturbances of autonomic nerve system are common in chronic renal failure with distinct abnormalities of parasympathetic function and additional sympathetic dysfunction. Elevated plasma norepinephrine seems to be related to the compensatory response of sympathetic nerve system to parasympathetic damage. Impairment of autonomic function does not appear specifically related to dialysis-induced hypotension or hypotension in chronic dialysis.
Autonomic Pathways
;
Blood Pressure
;
Catecholamines
;
Dialysis
;
Heart Rate
;
Humans
;
Hypotension
;
Kidney Failure, Chronic*
;
Norepinephrine
;
Plasma
;
Prevalence
;
Reflex
;
Renal Dialysis
;
Valsalva Maneuver
8.Assessment of myocardial perfusion during acute coronary occlusion and reperfusion by myocardial contrast echocardiography.
Youn Hoon KIM ; Hong Seog SEO ; Chang Gyu PARK ; Do Sun LIM ; Sang Jin KIM ; Wan Joo SHIM ; Dong Joo OH ; Jeong Euy PARK ; Young Moo RO
Korean Circulation Journal 1993;23(2):190-206
BACKGROUND: Myocardial contrast two-dimensional echocardiography(MC-2DE) has been known to have the real time capabilities for repeat in vivo assessment of ischemic risk areas and for evaluation of the myocardial perfusion. The aims of this investigation are (1) to evaluate the feasibility of MC-2DE for the delineation and quantitation of the area at risk. (2) to determine the relationship between the extent of the echocontrast defect area(EDA) during reperfusion and the size of myocardial infarction as determined by post-mortem tissue examination, and (3) to observe serial changes in the time echo-intensity characteristics of MC-2DE during coronary occlusion and reperfusion. METHODS: Myocardial contrast echocardiographic images were made by injecting bolus 5mL of two-syringe-agitated mixture of sodium meglumine ioxaglate(Hexabrix(R)) and normal saline(2 : 3 by volume) into the aortic root before and during coronary occlusion of the left anterior descending coronary artery, distal to the first diagonal branch and during reperfusion on eight open-chest dogs. Two-dimensional echocardiographic short axis views were obtained at four anatomic levels : the apex, the low papillary muscle, the high papillary muscle and the mitral valve. The changes in EDA and echo-intensity with its wash-out half time(WHT) at the high papillary muscle level during coronary occlusion and reperfusion were measured every 15 minutes. The total EDA was measured by planimetry at 3 minutes after coronary occlusion and at 60 minutes after reperfusion. Evans blue or methylene blue were used for the measurement of the anatomic area at risk and triphenyl-tetrazolium chloride(TTC) for the measurement of the infarct area. RESULTS: The EDA measured 30 minutes after coronary occlusion(19.6%) was smaller than that at 3 minutes after coronary occlusion(24.0%, p<0.01). Then EDA at 3 minutes occlusion was strongly predictive of the anatomic extent of area at risk(EDA=0.48 Area at risk+16.95, r=0.84, p<0.05). The EDA at 60 minutes after reperfusion, which showed an irregular margin and was located within the subendocardium of the area at risk, also correlated well with the infarct area(IA)(EDA=0.78 IA+3.32, r=0.82, p=0.09). The peak echo-intensity in the ischemic area during coronary occlusion was significantly low(14.2+/-6.5 vs 73.8+/-31.7 in the non-ischemic area, p<0.01) and the WHT was delayed more in the ischemic area than in the non-ischemic area(23.2+/-2.8 sec vs 8.1+/-3.3sec, p<0.01). During the period of reperfusion, WHT in the previously ischemic area was markedly delayed compared to that in the non-ischemic area (p<0.01), although the peak echo-intensity in the ischemic area at 3 minutes after reperfusion increased modestly compared to that in the non-ischemic area(80.9+/-22.8 vs 72.7+/-8.4), suggesting the impairment in the transit of microbubbles is probably due to microvascular damage after reperfusion. There were no adverse hemodynamic or electrocardiographic effects after injection of the contrast agent. CONCLUSIONS: These findings suggest that myocardial contrast echocardiography was useful as a non-invasive technique, first, to delineate the area at risk in vivo during coronary occlusion and, after reperfusion, the infarct area, and secondly, to evaluate indirectly the state of myocardial perfusion during coronary occlusion and reperfusion.
Animals
;
Axis, Cervical Vertebra
;
Coronary Occlusion*
;
Coronary Vessels
;
Dogs
;
Echocardiography*
;
Electrocardiography
;
Evans Blue
;
Hemodynamics
;
Meglumine
;
Methylene Blue
;
Microbubbles
;
Mitral Valve
;
Myocardial Infarction
;
Papillary Muscles
;
Perfusion*
;
Reperfusion*
;
Sodium
9.Clinical Outcomes of Descemet's Membrane Endothelial Keratoplasty: A 1-Year Retrospective Study.
Gyu Le HAN ; Joo HYUN ; Dong Hui LIM ; Eui Sang CHUNG ; Tae Young CHUNG
Journal of the Korean Ophthalmological Society 2015;56(10):1489-1496
PURPOSE: To evaluate the 1-year results of Descemet's membrane endothelial keratoplasty (DMEK) in Korea. METHODS: The medical records of 9 patients (10 eyes) with endothelial disease who underwent DMEK from January 2012 to December 2013, and were followed up for more than 12 months were reviewed retrospectively. RESULTS: In 8 eyes with successful results after surgery, best corrective visual acuity (BCVA) was significantly improved from 1.64 +/- 0.21 (log MAR, mean) to 0.35 +/- 0.22 at 1 month and was maintained at 12 months (p = 0.012, Wilcoxon signed ranks test). BCVA at postoperative 3, 6 and 12 months were gradually increased (0.25 +/- 0.23, 0.20 +/- 0.17 and 0.16 +/- 0.17 log MAR). Endothelial cell counts were 1,996 +/- 528/mm2, 1,564 +/- 174/mm2 and 1,463 +/- 541/mm2, 1,205 +/- 358/mm2 at 1, 3, 6, and 12 months after surgery, tended to decrease but showed no statistical significance. There was no statistical difference in astigmatism before and 3 months after the operation (3.32 +/- 2.36 diopter and 2.57+/- 1.44 diopter). Primary graft failure occurred in 2 eyes and 1 received reoperation. Total detachment was found in 1 eye. CONCLUSIONS: The 1-year results of DMEK showed fast visual recovery which was maintained for 12 months. DMEK may be a very efficient option for the surgical management of corneal endothelial disease.
Astigmatism
;
Cornea
;
Corneal Transplantation*
;
Descemet Membrane*
;
Endothelial Cells
;
Humans
;
Korea
;
Medical Records
;
Reoperation
;
Retrospective Studies*
;
Transplants
;
Visual Acuity
10.Relation between QT Dispersion and Late Potential in Acute Myocardial Infarction.
Do Sun LIM ; Young Hoon KIM ; Sang Chil LEE ; Chang Gyu PARK ; Hong Seog SEO ; Wan Joo SHIM ; Dong Joo OH ; Young Moo RO
Korean Circulation Journal 1996;26(2):442-448
BACKGROUND: QT dispersion(QTD=QTmax-QTmin) on the 12 lead ECG has been known to reflect regional variation of ventricular repolarization, and thus a marker of an increased risk of arrhythmia events. Late potential(LP) on signal averagina ECG(SAECG) is independent risk factor of ventricular arrhythmia following acute myocardial infaction(AMI). However, the relation between LP and QTD as indicator of electrophysiologic instability in AMI remains to be determined. METHOD: To determine whether there is a difference in QTD between in parients with AMI during acute phase and in normal control and whether thrombolytic therapy is assiciated with a reduction in QTD, and to determine the relationship between change of QTD and late potential on SAECG, we studied 71 patient with AMI(male 54, female 14, mean age 57yrs) and 23 controls(malw 17, female 6, mean age 58yrs). QT interval was measured on a standard 12 lead ECG in patients with AMI on admission, 2 hours after urokinase IV and 10-14 days post-AMI, and QT dispersion was calculated by difference of maximal and minimal corrected QT interval(QTmax-QTmin). A signal averaged ECG was recorded in 36 patients before discharge and coronary angiogeaphy(CAG) was performed in all patients 10-14 days post-AMI. RESULT: QTD is significantly increased in AMI compared to control(78.7+/-39.5ms vs. 24.6+/-22.3ms, P < 0.01). In patients who received thrombolytic therapy with urokinase, QTD is decreased from 75.0+/-34.4ms to 53.9+/-36.0ms(P < 0.01), whereas there is no significant change in patients who did not received thrombolytic therapy(84.8+/-47.6ms vs. 78.9+/-36.2ms, NS). There in no difference in QTD between patients with positive LP(68.4+/-23.6ms) and those with negative LP(77.8+/-32.1ms) on admission, those with positive LP(66.6+/-27.6ms) and those with negative LP(56.0+/-26.4ms) after 10-14days post-AMI. But magnitude of change of 10-14 days post-AMI QTD in patients with negative LP is larger than those with positive LP(-21.7+/-33.4ms vs. -1.8+/-15.2ms, P=0.06). CONCLUSION: QTD in acute phase of AMI is significantly reduced by the thrombolytic therapy. Patients with negative late potential tent to have greater QTD reduction within 14 days after AMI. These finding suggest that QT dispersion in patients with AMI can be reduced by early recanalization and its reduction is associated with the presence of late potential.
Arrhythmias, Cardiac
;
Electrocardiography
;
Female
;
Humans
;
Myocardial Infarction*
;
Risk Factors
;
Thrombolytic Therapy
;
Urokinase-Type Plasminogen Activator